Oshima, M., Jardine, M. J., Agarwal, R., Bakris, G., Cannon, C. P., Charytan, D. M., . . . Heerspink, H. J. L. (2021). Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice. Kidney international, 99(4), 999. https://doi.org/10.1016/j.kint.2020.10.042
Citace podle Chicago (17th ed.)Oshima, Megumi, et al. "Insights from CREDENCE Trial Indicate an Acute Drop in Estimated Glomerular Filtration Rate During Treatment with Canagliflozin with Implications for Clinical Practice." Kidney International 99, no. 4 (2021): 999. https://doi.org/10.1016/j.kint.2020.10.042.
Citace podle MLA (9th ed.)Oshima, Megumi, et al. "Insights from CREDENCE Trial Indicate an Acute Drop in Estimated Glomerular Filtration Rate During Treatment with Canagliflozin with Implications for Clinical Practice." Kidney International, vol. 99, no. 4, 2021, p. 999, https://doi.org/10.1016/j.kint.2020.10.042.